Molecular NeuroImaging Report issue

For profit Phase 1 Phase 2
Founded: New Haven CT United States (2000)
Status: Defunct (2019)

Organization Overview

First Clinical Trial
2000
NCT00132626
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Molecular NeuroImaging | Molecular Neuroimaging / Institute for Neurodegenerative Disorders | Molecular NeuroImaging, LLC | Molecular NeuroImaging, [MNI]